Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows From Operating Activities:
Net income	$ 242,180	$ 184,975
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	114,379	109,111
Amortization of debt issuance costs and discounts	4,685	4,842
Deferred income tax provision	78,056	8,892
Equity-based compensation	13,975	23,156
Other, including loss on sale or disposal of assets, net	11,906	3,121
Loss on early extinguishment of debt and write-off of discounts and debt issuance costs		52,011
Changes in assets and liabilities:
Accounts receivable	1,160	(73,695)
Inventories	(30,739)	4,938
Prepaid expenses and other current assets	(4,401)	1,667
Accounts payable and accrued expenses	11,176	27,969
Accrued salaries, wages and benefits	(2,996)	11,587
Deferred revenue	17,815	58,643
Other accrued liabilities	7,779	1,287
Right-of-use assets and operating lease liabilities	469	314
Other assets and liabilities	3,430	(2,381)
Net cash provided by operating activities	468,874	416,437
Cash Flows From Investing Activities:
Capital expenditures	(150,729)	(73,591)
Net cash used in investing activities	(150,729)	(73,591)
Cash Flows From Financing Activities:
Proceeds from issuance of debt, net		1,922,222
Repayments of long-term debt	(9,000)	(2,029,728)
Purchase of treasury stock	(617,756)	(77,566)
Payment of tax withholdings on equity-based compensation through shares withheld	(22,182)	(12,699)
Exercise of stock options	2,695	4,565
Debt issuance costs	(469)	(23,142)
Other financing activities	(427)	(6,565)
Net cash used in financing activities	(647,139)	(222,913)
Change in Cash and Cash Equivalents, including Restricted Cash	(328,994)	119,933
Cash and Cash Equivalents, including Restricted Cash—Beginning of period	444,486	435,225
Cash and Cash Equivalents, including Restricted Cash—End of period	115,492	555,158
Supplemental Disclosure of Noncash Investing and Financing Activities:
Capital expenditures in accounts payable	32,671	22,094
Treasury stock purchases not yet settled in other accrued liabilities	$ 5,298
Other financing arrangements		$ 4,239